6836 BEE CAVE ROAD, AUSTIN, TX
Market cap: $1.1B (2/09/2026)
Price: $5.27
Material disclosure
Investor Presentation
Material Contracts, Other Events
Announces $75M Royalty Funding Agreement To Support The Potential Launch Of MOLBREEVI In Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP), Investor Presentation
Shareholder votes
Savara Refused FDA Filing For Molbreevi* BLA in Autoimmune PAP Treatment
Annual Report to Security Holders
Q3
Q2
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence